Early mortality with hyper-hemolysis was evident with long term follow-up in the larger CCSCD population, and presumably this was due to previously unrecognized pulmonary hypertension as suggested by the higher prevalence of elevated NTproBNP levels. This evidence concerns the gene NPPB and pulmonary arterial hypertension.